• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

    2/10/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $INMD alert in real time by email

    YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025.

    InMode Logo (PRNewsfoto/InMode)

    Fourth Quarter 2025 Highlights:

    • Quarterly GAAP revenues of $103.9 million, compared to $97.9 million in the fourth quarter of 2024.
    • Quarterly revenues from consumables and service of $21.5 million, an increase of 8% compared to the fourth quarter of 2024.
    • GAAP operation income of $26 million, *non-GAAP operation income of $28.5 million.
    • Total cash position of $555.3 million as of December 31, 2025, including cash and cash equivalents, marketable securities and short-term bank deposits.

    Full Year 2025 Highlights:

    • Full year revenues of $370.5 million, a year-over-year decrease of 6%.
    • Full year revenues from consumables and service of $81.4 million, an increase of 3% compared to 2024.
    • GAAP operation income of $85.4 million, compared to $112.5 million in 2024; *non-GAAP operation income of $96.5 million, compared to $129.1 million in 2024.
    • Returned $127.4 million of capital to shareholders through repurchase of ordinary shares during 2025.

     

    U.S. GAAP Results

    (U.S. dollars in thousands, except for per share data)



    Q4 2025

    Q4 2024

    FY 2025

    FY 2024

    Revenues

    $103,854

    $97,853

    $370,495

    $394,818

    Gross Margins

    78 %

    79 %

    79 %

    80 %

    Net Income

    $27,025

    $82,771

    $93,831

    $181,275

    Earnings per Diluted Share

    $0.42

    $1.14

    $1.43

    $2.25

    *Non-GAAP Results

    (U.S. dollars in thousands, except for per share data)



    Q4 2025

    Q4 2024

    FY 2025

    FY 2024

    Gross Margins

    79 %

    80 %

    79 %

    81 %

    Net Income

    $29,429

    $31,081

    $105,495

    $142,707

    Earnings per Diluted Share

    $0.46

    $0.42

    $1.60

    $1.76

    *Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of

    Income
    is provided following the financial statements included in this release. Non-GAAP results exclude share-based compensation and tax benefit adjustments.

     

    Management Comments

    "While conditions across our industry remain challenging, we are seeing early signs of stabilization," said Moshe Mizrahy, Chief Executive Officer of InMode. "While the global uncertainties, particularly in North America, continue to weigh on overall demand, and the industry has yet to fully rebound, we are encouraged by the initial growth in Europe."

    "Looking ahead, in 2026 we plan on launching two new laser-based platforms. We see solid potential for these offerings across both our existing customer base and new customers and believe they will further strengthen our long-term market position," concluded Mizrahy.

    "Over the past year, we have unified our North American operations into a single organization encompassing the Eastern U.S., Western U.S., and Canada," said Michael Dennison, President of North America. "At the same time, we have refreshed our sales and post-sales leadership teams, strengthening our ability to serve customers across the region. With this foundation in place, we are entering 2026 with focus, alignment, and clear direction."

    Fourth Quarter and Full Year 2025 Financial Results

    Total GAAP revenues for the fourth quarter of 2025 were $103.9 million, an increase of 6% compared to $97.9 million in the fourth quarter of 2024. Total revenues for 2025 were $370.5 million, a decrease of 6% compared to 2024.

    Yair Malca, Chief Financial Officer of InMode added, "Our European operations achieved record revenue in the fourth quarter, reflecting continued momentum across the region and strong execution by our teams."

    GAAP gross margin for the fourth quarter of 2025 was 78%, compared to 79% for the fourth quarter of 2024. *Non-GAAP gross margin for the fourth quarter of 2025 was 79%, compared to 80% for the fourth quarter of 2024. GAAP gross margin for 2025 was 79%, compared to 80% for 2024. *Non-GAAP gross margin for 2024 was 79%, compared to 81% for 2024.

    GAAP operating margin for the fourth quarter of 2025 was 25%, compared to 28% in the fourth quarter of 2024. *Non-GAAP operating margin for the fourth quarter of 2025 was 27%, compared to 32% for the fourth quarter of 2024. GAAP operating margin for 2025 was 23%, compared to 29% in 2024. *Non-GAAP operating margin for 2025 was 26%, compared to 33% in the full year of 2024. This decrease was primarily attributable to higher sales and marketing expenses.

    InMode reported GAAP net income of $27.0 million, or $0.42 per diluted share, in the fourth quarter of 2025, compared to $82.8 million, or $1.14 per diluted share, in the fourth quarter of 2024. On a *non-GAAP basis, InMode reported net income of $29.5 million, or $0.46 per diluted share, in the fourth quarter of 2025, compared to $31.1 million, or $0.42 per diluted share, in the fourth quarter of 2024. GAAP net income was $93.9 million, or $1.43 per diluted share, in 2025, compared to GAAP net income of $181.3 million, or $2.25 per diluted share, in 2024. On a *non-GAAP basis, InMode reported net income of $105.5 million, or $1.60 per diluted share, in the full year of 2025, compared to net income of $142.7 million, or $1.76 per diluted share, for the full year in 2024. As a reminder, during Q4 of 2024, the Company released a valuation allowance related to its U.S. net deferred tax assets, and as a result recorded a one-time deferred tax asset of $55.1 million. Therefore, non-GAAP net income represents the most efficient basis for the comparison of year-over-year net results.

    As of December 31, 2025, InMode had cash and cash equivalents, marketable securities and short-term bank deposits of $555.3 million.

    "We ended the year with a strong balance sheet and returned $127.4 million of capital to shareholders through the repurchase of ordinary shares during 2025, underscoring our disciplined capital allocation and commitment to shareholder value," concluded Malca.

    2026 Financial Outlook

    Management provided an outlook for the full year of 2026 ending December 31, 2026. Based on current estimates, management expects:

    • Revenues between $365 million to $375 million
    • *Non-GAAP gross margin between 75% and 77%
    • *Non-GAAP income from operations to be between $87 million and $92 million
    • *Non-GAAP earnings per diluted share between $1.43 to $1.48


    This outlook is not a guarantee of future performance, and stockholders should not rely on such forward-looking statements. See "Forward-Looking Statements" for additional information.







    *Please refer to "Use of non-GAAP Financial Measures" below for important information about non-GAAP financial measures. A reconciliation between U.S. GAAP and non-GAAP Statement of Income is provided following the financial statements that are included in this release. Non-GAAP results exclude share-based compensation and tax benefit adjustments.

    However, these estimates are based on management's current estimates, which may be updated. 

    The Current Situation in Israel

    Regarding the current situation in Israel, on October 9, 2025, a new cease-fire agreement between Hamas and Israel began, and the hostilities have formally paused after two years of conflicts. The scope and severity of ongoing conflicts in Gaza, Northern Israel, Lebanon, Iran, and the broader region are unpredictable and could escalate any time. To date, our operations have not been materially affected. We continue to monitor political and military developments closely and examine the consequences for our operations and assets. 

    Use of Non-GAAP Financial Measures

    In addition to InMode's operating results presented in accordance with GAAP, this release contains certain non-GAAP financial measures including non-GAAP net income, non-GAAP earnings per diluted share, non-GAAP operating margin. Because these measures are used in InMode's internal analysis of financial and operating performance, management believes they provide investors with greater transparency of its view of InMode's economic performance. Management also believes the presentation of these measures, when analyzed in conjunction with InMode's GAAP operating results, allows investors to more effectively evaluate and compare InMode's performance to that of its peers, although InMode's presentation of its non-GAAP measures may not be strictly comparable to the similarly titled measures of other companies. Schedules reconciling each of these non-GAAP financial measures are provided as a supplement to this release.

    Conference Call Information

    Mr. Moshe Mizrahy, Chief Executive Officer, Dr. Michael Kreindel, Co-Founder and Chief Technology Officer and Mr. Yair Malca, Chief Financial Officer, will host a conference call today, February 10, 2026, at 8:30 a.m. Eastern Time to discuss the fourth quarter and full year 2025 financial results.

    The Company encourages participants to pre-register for the conference call using the following link: 

    https://dpregister.com/sreg/10205326/10099498542.

    Callers will receive a unique dial-in number upon registration, which enables immediate access to the call. Participants may pre-register at any time, including up to and after the call start time.

    For callers who opt out of pre-registration, please dial one of the following teleconferencing numbers. Please begin by placing your call 10 minutes before the conference call commences. If you are unable to connect using the toll-free number, please try the international dial-in number.

    U.S. Toll-Free Dial-in Number: 1-833-316-0562

    Israel Toll- Free Dial-in Number: 1-80-921-2373

    International Dial-in Number: 1-412-317-5736

    Webcast URL: https://event.choruscall.com/mediaframe/webcast.html?webcastid=Q835bTWk

    At:

    8:30 a.m. Eastern Time

    5:30 a.m. Pacific Time

    The conference call will also be webcast live from a link on InMode's website at https://inmodemd.com/investors/events-presentations/. A reply of the conference call will be available from February 10, 2026, at 12 p.m. Eastern Time to February 24 , 2026, at 11:59 p.m. Eastern Time. To access the replay, please dial one of the following numbers: 

    Replay Dial-in U.S./Canada TOLL-FREE: 1-855-669-9658

    Replay Dial-in TOLL/INTERNATIONAL: 1-412-317-0088

    Replay Pin Number: 9741895

    To access the replay using an international dial-in number, please select the link below:

    https://services.choruscall.com/ccforms/replay.html

    A replay of the conference call will also be available for 90 days on InMode's website at https://inmodemd.com/investors/.

    About InMode

    InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode, please visit www.inmodemd.com.

    Forward-Looking Statements

    The information in this press release includes forward-looking statements within the meaning of the federal securities laws. These statements generally relate to future events or InMode's future financial or operating performance, including the 2026 revenue projection described above. Actual outcomes and results may differ materially from what is expressed or forecast in such forward-looking statements. In some cases, you can identify these statements because they contain words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "predict," "project," "will," "would" and similar expressions that concern our expectations, strategic plans or intentions. Forward-looking statements are based on management's current expectations and assumptions, and are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Consequently, actual results could differ materially from those indicated in these forward-looking statements. When considering these forward-looking statements, you should keep in mind the risk factors and other cautionary statements included in InMode's Annual Report on Form 20-F filed with the Securities and Exchange Commission on February 4, 2025, and our subsequent public filings. InMode undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which pertain only as of the date of this press release.

     

    Company Contact:

    Yair Malca

    Chief Financial Officer

    Phone: (949) 305-0108

    Email: [email protected]

    Investor Relations Contact:

    Miri Segal

    MS-IR LLC

    Email: [email protected]

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF INCOME

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)



    Three months ended

    December 31,



    Year Ended

    December 31,



    2025



    2024



    2025



    2024

    REVENUES

    103,854



    97,853



    370,495



    394,818

    COST OF REVENUES

    22,554



    20,216



    79,525



    77,752

    GROSS PROFIT

    81,300



    77,637



    290,970



    317,066

    OPERATING EXPENSES:















    Research and development

    3,509



    2,667



    13,319



    13,137

    Sales and marketing

    48,407



    44,653



    180,578



    181,366

    General and administrative

    3,393



    2,453



    11,686



    10,032

    TOTAL OPERATING EXPENSES

    55,309



    49,773



    205,583



    204,535

    OPERATIONS INCOME

    25,991



    27,864



    85,387



    112,531

    Finance income, net

    5,301



    4,346



    24,943



    30,938

    INCOME BEFORE INCOME TAXES

    31,292



    32,210



    110,330



    143,469

    INCOME TAXES BENEFIT (EXPENSES)

    (4,267)



    50,561



    (16,499)



    37,806

    NET INCOME

    27,025



    82,771



    93,831



    181,275

















    EARNINGS PER SHARE:















    Basic

    0.43



    1.15



    1.45



    2.29

    Diluted

    0.42



    1.14



    1.43



    2.25

    WEIGHTED AVERAGE NUMBER OF SHARES

    OUTSTANDING USED IN COMPUTATION OF

    EARNINGS PER SHARE (in thousands)















    Basic

    63,335



    71,874



    64,633



    79,306

    Diluted

    64,082



    72,787



    65,445



    80,597

     

     

    INMODE LTD.

    CONDENSED CONSOLIDATED BALANCE SHEETS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)



    December 31,

    2025



    December 31,

    2024

    Assets







    CURRENT ASSETS:







    Cash and cash equivalents

    302,543



    155,329

    Marketable securities (amortized cost of $83,542 and $268,129, as of

    December 31, 2025 and 2024, respectively)

    83,632



    267,688

    Short-term bank deposits

    169,159



    173,455

    Accounts receivable, net of allowance for credit losses of $2,371 and

    $1,825, as of December 31, 2025 and 2024, respectively

    43,504



    36,335

    Prepaid expenses and other receivables

    25,733



    22,097

    Inventories

    74,050



    59,548

             TOTAL CURRENT ASSETS

    698,621



    714,452

        NON-CURRENT ASSETS:







    Accounts receivable, net of allowance for credit losses of $856 and $924

    as of December 31, 2025 and 2024, respectively

    3,005



    3,176

    Deferred income tax asset

    53,230



    56,285

    Operating lease right-of-use assets

    8,274



    8,732

    Property and equipment, net

    2,599



    2,322

    Other investments

    700



    700

    TOTAL NON-CURRENT ASSETS

    67,808



    71,215

    TOTAL ASSETS

    766,429



    785,667

    Liabilities and shareholders' equity







    CURRENT LIABILITIES:







    Accounts payables

    17,912



    13,782

    Contract liabilities

    12,093



    16,755

    Other liabilities

    40,739



    39,314

    TOTAL CURRENT LIABILITIES

    70,744



    69,851

        NON-CURRENT LIABILITIES:







    Contract liabilities

    3,043



    3,336

    Other liabilities

    4,436



    3,356

    Operating lease liabilities

    5,008



    5,311

    TOTAL NON-CURRENT LIABILITIES

    12,487



    12,003

    TOTAL LIABILITIES

    83,231



    81,854









    TOTAL SHAREHOLDERS' EQUITY

    683,198



    703,813

    TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY

    766,429



    785,667

     

     

    INMODE LTD.

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)





    Three months ended

    December 31,



    Year Ended

    December 31,



    2025



    2024



    2025



    2024



    CASH FLOWS FROM OPERATING ACTIVITIES:

















    Net income

    27,025



    82,771



    93,831



    181,275



    Adjustments required to reconcile net income to net cash provided by operating activities:

















    Depreciation

    174



    248



    695



    728



    Share-based compensation expenses

    2,499



    3,447



    11,131



    16,569



    Change in allowance for credit losses of trade receivable

    295



    158



    454



    572



    Loss (Gain) on marketable securities, net

    1



    (3)



    15



    167



    Finance expenses (income), net

    (762)



    1,533



    498



    (4,401)



    Deferred income tax assets, net

    864



    (55,121)



    2,928



    (55,179)



    Changes in operating assets and liabilities:

















    Decrease (increase) in accounts receivable (current and non-current)

    (6,358)



    4,025



    (7,452)



    5,949



    Decrease (increase) in other receivables

    (1,275)



    1,879



    (3,678)



    (5,698)



    Increase in inventories

    (2,647)



    (1,264)



    (14,502)



    (14,453)



    Increase (decrease) in accounts payable

    1,188



    (531)



    4,129



    (184)



    Increase (decrease) in other liabilities (current and non-current)

    4,759



    (4,243)



    2,163



    1,917



    Increase (decrease) in contract liabilities (current and non-current)

    (3,089)



    (457)



    (4,955)



    5,402



    Net cash provided by operating activities

    22,674



    32,442



    85,257



    132,664



    CASH FLOWS FROM INVESTING ACTIVITIES:

















       Investment in short-term deposits

    (113,733)



    (3,500)



    (292,637)



    (168,187)



       Proceeds from short-term deposits

    103,389



    67,100



    293,076



    218,740



       Purchase of fixed assets

    (534)



    (234)



    (972)



    (669)



       Purchase of marketable securities

    –



    (59,708)



    (20,877)



    (336,221)



       Proceeds from sale of marketable securities

    –



    21,146



    17,214



    90,754



       Proceeds from maturity of marketable securities

    38,101



    53,012



    190,228



    357,789



    Net cash provided by investing activities

    27,223



    77,816



    186,032



    162,206



    CASH FLOWS FROM FINANCING ACTIVITIES:

















      Repurchase of ordinary shares

    -



    (119,849)



    (127,444)



    (285,385)



           Exercise of options

    137



    1,420



    1,385



    2,614



    Net cash provided by (used in) financing activities

    137



    (118,429)



    (126,059)



    (282,771)



    EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

    72



    (1,338)



    1,984



    (1,181)



    NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

    50,106



    (9,509)



    147,214



    10,918



    CASH AND CASH EQUIVALENTS AT BEGINNING OF YEAR                       

    252,437



    164,838



    155,329



    144,411



    CASH AND CASH EQUIVALENTS AT END OF YEAR

    302,543



    155,329



    302,543



    155,329



     

    INMODE LTD.

    CONDENSED CONSOLIDATED FINANCIAL HIGHLIGHTS

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)



    Three months ended December 31,



    Year ended December 31,

    2025





    2024





    2025





    2024

    Revenues by Category:































































    Capital Equipment revenues - United States

    46,760



    45 %



    53,128



    55 %



    162,158



    44 %



    204,520



    52 %

    Capital Equipment revenues - International

    35,631



    34 %



    24,836



    25 %



    126,960



    34 %



    111,027



    28 %

    Total Capital Equipment revenues

    82,391



    79 %



    77,964



    80 %



    289,118



    78 %



    315,547



    80 %

    Consumables and service revenues

    21,463



    21 %



    19,889



    20 %



    81,377



    22 %



    79,271



    20 %

    Total Revenue

    103,854



    100 %



    97,853



    100 %



    370,495



    100 %



    394,818



    100 %







































     



    Three months ended December 31,



    Year ended December 31,

    2025



    2024



    2025



    2024



    %



    %



    %



    %



    United States



    International



    Total



    United States



    International



    Total



    United States



    International



    Total



    United States



    International



    Total

    Revenues by Technology:















































    Minimal-Invasive

    76



    75



    76



    93



    76



    86



    78



    78



    78



    92



    80



    87

    Hands-Free

    1



    2



    1



    5



    3



    5



    3



    2



    2



    6



    3



    5

    Non-Invasive

    23



    23



    23



    2



    21



    9



    19



    20



    20



    2



    17



    8



    100



    100



    100



    100



    100



    100



    100



    100



    100



    100



    100



    100

     

     

    INMODE LTD.

    RECONCILIATION OF GAAP CONDENSED CONSOLIDATED STATEMENTS OF

    INCOME TO NON-GAAP CONDENSED CONSOLIDATED STATEMENTS OF INCOME 

    (U.S. dollars in thousands, except for per share data)

    (Unaudited)











    Three months ended December 31, 2025





    Three months ended December 31, 2024

    GAAP



    Share Based

    Compensation



    Non-GAAP



    GAAP



    Share Based

    Compensation



    Tax benefit (1)



    Non-GAAP

    REVENUES

    103,854



    -



    103,854



    97,853



    -



    -



    97,853

    COST OF REVENUES

    22,554



    (346)



    22,208



    20,216



    (472)



    -



    19,744

    GROSS PROFIT

    81,300



    346



    81,646



    77,637



    472



    -



    78,109

    OPERATING EXPENSES:



























    Research and development

    3,509



    (256)



    3,253



    2,667



    (300)



    -



    2,367

    Sales and marketing

    48,407



    (1,589)



    46,818



    44,653



    (2,360)



    -



    42,293

    General and administrative

    3,393



    (308)



    3,085



    2,453



    (315)



    -



    2,138

    TOTAL OPERATING

    EXPENSES

    55,309



    (2,153)



    53,156



    49,773



    (2,975)



    -



    46,798

    OPERATIONS INCOME

    25,991



    2,499



    28,490



    27,864



    3,447



    -



    31,311

    Finance income, net

    5,301



    -



    5,301



    4,346



    -



    -



    4,346

    INCOME BEFORE INCOME TAXES

    31,292



    2,499



    33,791



    32,210



    3,447



    -



    35,657

    INCOME TAXES BENEFIT (EXPENSES)

    (4,267)



    (95)



    (4,362)



    50,561



    -



    (55,137)



    (4,576)

    NET INCOME

    27,025



    2,404



    29,429



    82,771



    3,447



    (55,137)



    31,081





























    EARNINGS PER SHARE:



























    Basic

    0.43







    0.46



    1.15











    0.43

    Diluted

    0.42







    0.46



    1.14











    0.42

    WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands)



























    Basic

    63,335







    63,335



    71,874











    71,874

    Diluted

    64,082







    64,443



    72,787











    73,139

































    (1) Tax benefit recorded during the year ended December 31, 2024, as a result of a release of valuation allowance on our deferred tax assets in the United States as it is more likely than not that our net deferred tax assets will be realized given our expectation of profitability in future periods.

     

     



    Year Ended December 31, 2025



    Year Ended December 31, 2024

    GAAP



    Share Based

    Compensation



    Non-GAAP





    GAAP



    Share Based

    Compensation



    Tax benefit (1)



    Non-GAAP

    REVENUES

    370,495







    370,495





    394,818



    -



    -



    394,818

    COST OF REVENUES

    79,525



    (1,333)



    78,192





    77,752



    (1,833)



    -



    75,919

    GROSS PROFIT

    290,970



    1,333



    292,303





    317,066



    1,833



    -



    318,899

    OPERATING EXPENSES:





























    Research and development

    13,319



    (1,039)



    12,280





    13,137



    (2,177)



    -



    10,960

    Sales and marketing

    180,578



    (7,685)



    172,893





    181,366



    (11,367)







    169,999

    General and administrative

    11,686



    (1,074)



    10,612





    10,032



    (1,192)



    -



    8,840

    TOTAL OPERATING

    EXPENSES

    205,583



    (9,798)



    195,785





    204,535



    (14,736)



    -



    189,799

    OPERATIONS INCOME

    85,387



    11,131



    96,518





    112,531



    16,569



    -



    129,100

    Finance income, net

    24,943



    -



    24,943





    30,938



    -



    -



    30,938

    INCOME BEFORE INCOME TAXES

    110,330



    11,131



    121,461





    143,469



    16,569



    -



    160,038

    INCOME TAXES BENEFIT (EXPENSES)

    (16,499)



    533



    (15,966)





    37,806



    -



    (55,137)



    (17,331)

    NET INCOME

    93,831



    11,664



    105,495





    181,275



    16,569



    (55,137)



    142,707































    EARNINGS PER

    SHARE:





























    Basic

    1.45







    1.63





    2.29











    1.80

    Diluted

    1.43







    1.60





    2.25











    1.76

    WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING USED IN COMPUTATION OF EARNINGS PER SHARE (in thousands)





























    Basic

    64,633







    64,633





    79,306











    79,306

    Diluted

    65,445







    65,756





    80,597











    80,943

































    (1) Tax benefit recorded during the year ended December 31, 2024, as a result of a release of valuation allowance on our deferred tax assets in the United States as it is more likely than not that our net deferred tax assets will be realized given our expectation of profitability in future periods.

     

    Logo - https://mma.prnewswire.com/media/1064477/5779813/InMode_Logo.jpg

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/inmode-reports-fourth-quarter-and-full-year-2025-financial-results-quarterly-gaap-revenue-of-103-9-million-and-full-year-revenue-of-370-5-million-302683050.html

    SOURCE InMode Ltd.

    Get the next $INMD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $INMD

    DatePrice TargetRatingAnalyst
    4/29/2025Buy → Neutral
    BTIG Research
    4/28/2025$22.00 → $16.00Outperform → Neutral
    Robert W. Baird
    10/17/2024$25.00Buy
    BTIG Research
    7/23/2024$21.00 → $19.00Buy → Hold
    Jefferies
    11/3/2023$52.00 → $24.00Buy → Neutral
    UBS
    10/13/2023$55.00 → $22.00Buy → Hold
    Canaccord Genuity
    3/29/2023$40.00Buy
    UBS
    2/17/2023Buy → Hold
    Needham
    More analyst ratings

    $INMD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    InMode downgraded by BTIG Research

    BTIG Research downgraded InMode from Buy to Neutral

    4/29/25 8:06:22 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode downgraded by Robert W. Baird with a new price target

    Robert W. Baird downgraded InMode from Outperform to Neutral and set a new price target of $16.00 from $22.00 previously

    4/28/25 1:56:11 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    BTIG Research initiated coverage on InMode with a new price target

    BTIG Research initiated coverage of InMode with a rating of Buy and set a new price target of $25.00

    10/17/24 7:41:34 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    SEC Filings

    View All

    SEC Form S-8 filed by InMode Ltd.

    S-8 - InMode Ltd. (0001742692) (Filer)

    2/10/26 7:38:08 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 20-F filed by InMode Ltd.

    20-F - InMode Ltd. (0001742692) (Filer)

    2/10/26 7:33:27 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form 6-K filed by InMode Ltd.

    6-K - InMode Ltd. (0001742692) (Filer)

    2/10/26 7:29:05 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

    YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025. Fourth Quarter 2025 Highlights: Quarterly GAAP revenues of $103.9 million, compared to $97.9 million in the fourth quarter of 2024.Quarterly revenues from consumables and service of $21.5 million, an increase of 8% compared to the fourth quarter of 2024.GAAP operation income of $26 million, *non-GAAP operation income of $28.5 million.Total cash position of $555.3 million as of December 31, 2025, including cash and cash equivalents, marketable securiti

    2/10/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

    YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 11, 2026. Interested investors are welcome to contact their BTIG salesperson and schedule a meeting. For more information about the event, visit InMode's investor relations site here. About InMode InMode is a leading global provider of innov

    2/3/26 8:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode Responds to Transaction Rumors

    YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement: The Company is aware of recent market speculation and rumors, including reports relating to the publicly announced non-binding proposal by Steel Partners Holdings L.P. to acquire 51% of the Company's outstanding shares and recent statements attributed to the Company's Chief Executive Officer. Without derogating from the Company's general policy that it does not comment on market rumors, the Company wishes to inform investors that it is currently evaluating potential strategic alternatives. In

    2/2/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Financials

    Live finance-specific insights

    View All

    InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

    YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025. Fourth Quarter 2025 Highlights: Quarterly GAAP revenues of $103.9 million, compared to $97.9 million in the fourth quarter of 2024.Quarterly revenues from consumables and service of $21.5 million, an increase of 8% compared to the fourth quarter of 2024.GAAP operation income of $26 million, *non-GAAP operation income of $28.5 million.Total cash position of $555.3 million as of December 31, 2025, including cash and cash equivalents, marketable securiti

    2/10/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M

    Conference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the fourth quarter and full year of 2025 before the Nasdaq market opens on Tuesday, February 10, 2026. InMode is currently finalizing its financial results for the fourth quarter and full year of 2025. While complete financial information and operating data are not yet available, set forth below are certain preliminary results of InMode's financial results for such period, subject to final adjustments and ot

    1/8/26 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

    YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025. Third Quarter 2025 Highlights: Quarterly GAAP revenues of $93.2 million, compared to $130.2 million in the third quarter of 2024, which included $31.9 million of pre-order sales.Quarterly revenues from consumables and service of $19.9 million, an increase of 26% compared to the third quarter of 2024.GAAP operating income of $20.9 million. *Non-GAAP operating income was $23.6 million.Total cash position of $532.3 million as of September 30, 2025, incl

    11/5/25 7:00:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

    SC 13G/A - InMode Ltd. (0001742692) (Subject)

    2/13/24 4:31:18 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G/A filed by InMode Ltd. (Amendment)

    SC 13G/A - InMode Ltd. (0001742692) (Subject)

    2/13/24 4:25:40 PM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    SEC Form SC 13G filed by InMode Ltd.

    SC 13G - InMode Ltd. (0001742692) (Subject)

    2/6/24 9:36:39 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $INMD
    Leadership Updates

    Live Leadership Updates

    View All

    InMode Appoints Michael Dennison as President of North America

    IRVINE, Calif., Nov. 3, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ:INMD), a leading global provider of innovative medical technologies, has appointed Michael Dennison, most recently Vice President of Sales, as President of North America.  Dennison has held nearly every sales position in the aesthetic medical device industry, consistently producing at the highest level in each. With close to a decade of leadership experience at InMode, Dennison has advanced through roles from District Sales Manager to Vice President of Sales, driving national revenue growth, expanding market shar

    11/3/25 8:05:00 AM ET
    $INMD
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care